Cabozantinib has achieved its primary endpoint of overall survival (OS) through demonstrating a statistically significant and clinically meaningful improvement in median OS compared to placebo in patients with
Allergan said that it will appeal against the ruling given by Judge William Bryson in the United States District Court for the Eastern District of Texas. The lawsuit
All the ten members of the FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee voted in favor of netarsudil ophthalmic solution, which is intended to be used daily once.
The investigational adeno-associated viral (AAV) vector gene therapy was unanimously approved by all the 16 members of the Cellular, Tissue and Gene Therapies Advisory Committee of the drug
Founded in 2012, Symbiomix Therapeutics, which is based in Newark, New Jersey, is focused on developing therapies for gynecologic infections that can have serious health implications. Through its
The new facility is being developed to support the firm’s global vaccines business unit to expand supply of VaxigripTetra to around 70 countries in six continents. As per
The US-based pharma giant said that it may consider a full or partial separation of Pfizer Consumer Healthcare either through a spin-off or other transaction apart from the
The BTD designation granted by the US Food and Drug Administration (FDA) is indicated for the treatment of metastatic NSCLC patients who are growth factor receptor (EGFR) mutation-positive. It
The company has recruited first patient in the trial of NanoPac sterile suspension in patients with ovarian cancer. The trial will assess NanoPac’s safety and efficacy after IP
The study is assessing the efficacy and safety of anticoagulant medicine for the secondary prevention of stroke and systemic embolism in patients with a recent embolic stroke of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.